Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-26 @ 8:19 AM
Study NCT ID:
NCT00608959
Status:
COMPLETED
Last Update Posted:
2010-01-26
First Post:
2008-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
Sponsor:
Cadence Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
UNKNOWN
Study ID:
CPI-226-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Catherine Hardalo, MD. Vice President, Anti Infectives Clinical Development
Old Organization:
Cadence Pharmaceuticals,Inc.